ArticlePloS one2021

Risk factors for severe neutropenia in pancreatic cancer patients treated with gemcitabine/nab-paclitaxel combination therapy.

Genta Ito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.